Bright Minds Biosciences (TSE:DRUG)
:DRUG
Want to see TSE:DRUG full AI Analyst Report?
DRUG Analyst Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
DRUG Stock 12 Month Forecast
Average Price Target
C$225.94
▲(82.94% Upside)
| Highest Price TargetC$302.62 | Average Price TargetC$225.94 | Lowest Price TargetC$199.46 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Piper Sandler
C$261.36→C$302.62
Buy
145.04%
Upside
Assigned
05/20/26
TD Cowen
―
Buy
―
Reiterated
05/20/26
10:00 PM Bright Minds Biosciences (NASDAQ: DRUG) Buy (1) ESG No Surprises In The Quarter As 2026 Remains A Report THE TD COWEN INSIGHT DRUG reported a FQ2 net loss of CAD $10MM and had cash and equivalents of CAD $309.7MM. Data from the Ph. IIa trial of BMB-101 in DEE/absence exceeded expectations and DRUG plans to initiate registrational studies in both indications in 2026. A Ph. IIa POC of BMB-101 in PWS is starting up. 2026 is a year of execution though DRUG remains highly undervalued based on KOL support. Buy. And DEE 2026, DRUG reported topline data from the open-label Ph. IIa trial of BMB-101 in absence and DEE seizures.
Jefferies
C$199.46
Buy
61.50%
Upside
Initiated
04/12/26
BTIG
C$202.21
Buy
63.73%
Upside
Reiterated
03/30/26
H.C. Wainwright
C$158.19→C$199.46
Buy
61.50%
Upside
Reiterated
03/05/26
Robert W. Baird
C$195.33→C$173.32
Buy
40.34%
Upside
Reiterated
02/13/26
Cantor Fitzgerald
―
Buy
―
Initiated
07/02/25
Wolfe Research
C$110.05
Buy
-10.89%
Downside
Reiterated
05/21/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
C$261.36→C$302.62
Buy
145.04%
Upside
Assigned
05/20/26
TD Cowen
―
Buy
―
Reiterated
05/20/26
10:00 PM Bright Minds Biosciences (NASDAQ: DRUG) Buy (1) ESG No Surprises In The Quarter As 2026 Remains A Report THE TD COWEN INSIGHT DRUG reported a FQ2 net loss of CAD $10MM and had cash and equivalents of CAD $309.7MM. Data from the Ph. IIa trial of BMB-101 in DEE/absence exceeded expectations and DRUG plans to initiate registrational studies in both indications in 2026. A Ph. IIa POC of BMB-101 in PWS is starting up. 2026 is a year of execution though DRUG remains highly undervalued based on KOL support. Buy. And DEE 2026, DRUG reported topline data from the open-label Ph. IIa trial of BMB-101 in absence and DEE seizures.
Jefferies
C$199.46
Buy
61.50%
Upside
Initiated
04/12/26
BTIG
C$202.21
Buy
63.73%
Upside
Reiterated
03/30/26
H.C. Wainwright
C$158.19→C$199.46
Buy
61.50%
Upside
Reiterated
03/05/26
Robert W. Baird
C$195.33→C$173.32
Buy
40.34%
Upside
Reiterated
02/13/26
Cantor Fitzgerald
―
Buy
―
Initiated
07/02/25
Wolfe Research
C$110.05
Buy
-10.89%
Downside
Reiterated
05/21/25
Best Analysts Covering Bright Minds Biosciences
3 Months
Success Rate
4/5 ratings generated profit
Average Return
+26.52%
Copying Thomas Shrader's trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +26.52% per trade.
1 Year
Success Rate
7/10 ratings generated profit
Average Return
+67.85%
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +67.85% per trade.
2 Years
Success Rate
7/10 ratings generated profit
Average Return
+61.84%
Copying Patrick Trucchio's trades and holding each position for 2 Years would result in 70.00% of your transactions generating a profit, with an average return of +61.84% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
DRUG Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
3
5
7
6
4
Buy
7
7
3
1
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
12
10
7
5
Each month's total comprises the sum of three months' worth of ratings.
DRUG Financial Forecast
DRUG Stock Forecast FAQ
What is TSE:DRUG’s average 12-month price target, according to analysts?
Based on analyst ratings, Bright Minds Biosciences’s 12-month average price target is 225.94.
What is TSE:DRUG’s upside potential, based on the analysts’ average price target?
Bright Minds Biosciences has 82.94% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TSE:DRUG a Buy, Sell or Hold?
Bright Minds Biosciences has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Bright Minds Biosciences’s price target?
The average price target for Bright Minds Biosciences is 225.94. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is C$302.62 ,the lowest forecast is C$199.46. The average price target represents 82.94% Increase from the current price of C$123.5.
The highest analyst price target is C$302.62 ,the lowest forecast is C$199.46. The average price target represents 82.94% Increase from the current price of C$123.5.
What do analysts say about Bright Minds Biosciences?
Bright Minds Biosciences’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of TSE:DRUG?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.